References

1.  Induced Abortion. ACOG Patient Education Pamphlet, American College of     Obstetricians and Gynecologists.  June 2007.

2.  Rock J, Thompson J. Telinde’s Operative Gynecology, 8th edition, Lippincott-Raven, 1997.

3.  Induced Abortion. ACOG.

4.  Rock J, Thompson J.  TeLinde’s Operative Gynecology.

5.  Stenchever M, et al. Comprehensive Gynecology, 4th edition, Mosby, Inc., 2001.

6.  Fox MC, et al. Cervical Preparation for Second Trimester Surgical Abortion Prior to      20 Weeks.  Contraception 2007; 76(6):486-95.

7.  Rock J, Thompson J. TeLinde’s Operative Gynecology.

8.  http:www.drhern.com/medicalprocedures.asp; Boulder Abortion Clinic, P.C. (accessed June 16, 2008).

9.  Pasquini L, et al. Intracardiac injection of potassium chloride as method for feticide: experience from a single UK tertiary centre. British Journal of Obstetrics & Gynecology 2008; 115(4):528-31.

10.  Mifeprex (Mifepristone) Information. Center for Drug Evaluation and Research, U.S. Food and Drug Administration, http://www.fda.gov/cder/drug/infopage/mifepristone/ (accessed June 16, 2008).

11.  Mifeprex Package Insert (U.S. Food and Drug Administration-approved label), July 2005.

12.  Gary M, Harrision D. Analysis of severe adverse events related to the use of Mifepristone as an abortifacient.  The Annals of Pharmacology 2006; 40.

13.  Medical Management of Abortion.  ACOG Practice Bulletin No. 67. American College of Obstetricians and Gynecologists October 2005.